Please assess the completion status of the following clinical trial:

Trial Title: Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Children aged between 2 months and 12 years~* Presenting with generalised convulsions~Exclusion Criteria:~* Any child who had received an anticonvulsant agent within 1 hour of presentation~* Seizure stopped with rapid cooling or treatment of hypoglycaemia~* Features consistent with organophosphate poisoning, hepatic or hypertensive encephalopathy

- Gender: ALL
- Minimum Age: 2 Months
- Maximum Age: 12 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).